The Cycle, Explained

Estrogen

lowest of the cycle — just dropped from luteal peak

Progesterone

at floor — crashed from luteal high

FSH

beginning to rise

Prostaglandins

elevated — driving cramps

LH

low

Cramps

Fatigue

Lower back and hip pain

Emotional tenderness / crying

Digestive changes

Headache (for some)

Counterintuitive clarity

Estrogen

rising steadily — the dominant hormone of this phase

FSH

elevated early, then declining as dominant follicle emerges

Progesterone

minimal

LH

building slowly

Testosterone

beginning to rise gently

Energy surge

Improved mood and motivation

Better sleep

Sharpened cognitive function

Clearer skin

Higher pain tolerance

Cervical fluid changes

LH

the surge — this is what triggers ovulation

Estrogen

at its monthly maximum

FSH

small secondary surge alongside LH

Testosterone

peaks at ovulation

Progesterone

about to start rising

Peak energy and confidence

Heightened libido

Mittelschmerz (ovulation pain)

Social and verbal peak

Heightened senses

Cervical fluid peak

Breast tenderness beginning

Progesterone

rises to peak (days 19–22) then falls

Estrogen

second smaller peak then declining

Allopregnanolone

rises with progesterone, then crashes

Serotonin

inversely tracks progesterone — drops as progesterone falls

Cortisol sensitivity

heightened in late luteal

Early luteal: calm and nourished

Increased appetite (300–500 kcal/day)

Bloating

Breast tenderness

Late luteal: mood volatility, irritability, anxiety

Fatigue and cognitive slowdown

Sleep disruption (late luteal)

Heaviest periods of any profile. Clotting is common. Cramping amplified by high estrogen-to-progesterone ratio throughout the cycle. Fatigue is compounded by iron loss. The "fresh start" cognitive lift at period onset is often delayed by the severity of symptoms.

Good energy early. Rising estrogen adds to an already-high baseline — can feel great, energized, ambitious. But breast tenderness and bloating often persist into the follicular phase rather than fully resolving.

Strong peak, but estrogen is extra high relative to the norm. Heightened libido, social drive, and confidence — but breast tenderness at its worst and bloating peaks here too.

The hardest phase. Progesterone is insufficient to counterbalance elevated estrogen. PMS symptoms — mood swings, bloating, breast pain, water retention — are pronounced. The hormonal drop at the end is felt acutely.

When a period does arrive, it may follow a long, irregular wait. The period itself can be longer or heavier than typical. Cramping varies widely. The cycle's hormonal 'rules' are less predictable.

Follicular development is disrupted by elevated LH and androgens — multiple follicles partially develop but none dominate cleanly. Energy and mood are less reliably improved than in a typical follicular phase. Insulin resistance means the metabolic boost is muted.

Ovulation may not occur every cycle, or may occur late (cycle day 20–40). When it does happen, the LH surge is often exaggerated. The peak is real but arrives on a different timeline than expected.

If ovulation was skipped, there is no corpus luteum and no luteal progesterone rise — meaning the typical luteal symptoms (fatigue, mood changes, appetite increase) may be absent, replaced by a prolonged follicular-like state that simply ends in a breakthrough bleed.

The relief phase. For PMDD, menstruation often brings a dramatic and near-instant mood lift. The period starting means progesterone and allopregnanolone have fully cleared — and the neurological hypersensitivity resolves. Many people with PMDD describe period day 1 as one of their best days of the month.

The longest good stretch of the cycle. Without progesterone in the system, the GABA-A sensitivity issue is dormant. Energy, mood, and social drive return fully. Cognitive performance normalizes.

Peak in the same way as any cycle, though some PMDD-prone people note a sensitivity around the LH surge. The hormonal transition from purely estrogen-dominant to the start of progesterone rise can trigger a brief wobble.

The clinical territory. For PMDD, the rising and then crashing allopregnanolone is experienced as a neurological provocation rather than a gentle sedative effect. Anxiety, rage, despair, dissociation, and functional impairment emerge 7–14 days before the period and resolve within 48 hours of bleeding. This is not personality — it is a brain response to a hormone withdrawal the brain is hypersensitive to.

Increasingly variable. Cycles are getting shorter or longer. Periods may be lighter for a while, then suddenly very heavy. The hormonal floor that once was predictable is now unstable.

FSH is high and rising — the pituitary is pushing hard to recruit follicles from a declining ovarian reserve. Estrogen can swing wildly: sometimes a very strong follicular rise (triggering intense estrogen-dominant symptoms), sometimes a flat, blunted one. The follicular phase often shortens.

Ovulation still occurs but is less reliable. Some cycles become anovulatory. When ovulation does happen, the LH surge may be exaggerated. Hot flashes can occur throughout the cycle but are often worst around ovulation.

Progesterone levels in the luteal phase decline years before estrogen does. The result is a long period of relative estrogen dominance with insufficient progesterone buffer — driving classic perimenopausal symptoms: sleep disruption, mood volatility, night sweats, anxiety. The luteal phase often shortens.

Day 1 is data. Cycle day tracking starts now. Menstrual characteristics (duration, flow, color) are clinical signals about the uterine lining. A short bleed may suggest thin lining. Heavy clotting raises questions worth investigating.

The growth window for the next potential egg. Follicular phase length matters — too short (< 10 days) leaves insufficient time for a dominant follicle to fully mature. Too long may signal follicle recruitment issues. Ovarian response to FSH is the key mechanism being supported.

The window. Accurately identifying the LH surge is the entire game in natural TTC. The fertile window is typically 5 days — the 3–4 days before ovulation and ovulation day itself. Cervical fluid tracking alongside LH testing improves accuracy over LH strips alone.

The implantation window. A luteal phase shorter than 10 days is clinically significant — there is insufficient time for implantation. Progesterone must remain elevated until the placenta can take over production (week 8–10 of pregnancy). A spotting-before-period pattern or short luteal is worth discussing with a reproductive endocrinologist.

Often spotting 2–5 days before the actual period starts — brown spotting that's technically still the luteal phase. The full flow may be shorter once it begins, and often lighter than average.

This is the strong phase for low-progesterone people. Without their already-low progesterone in the picture, they tend to feel very well in the follicular phase — energized, clear, functioning.

Generally good. Estrogen and testosterone drive the typical ovulatory lift. The low-progesterone pattern doesn't cause issues in the first half of the cycle.

The defining challenge. Progesterone rises but doesn't reach adequate levels. Sleep quality deteriorates even in early luteal. Anxiety, nervousness, and a sense of impending emotional instability arrive earlier in the luteal phase than for typical cycles. Pre-period spotting begins days before the actual flow.

Iron loss is a real performance concern. Even sub-clinical iron depletion — ferritin below 30 ng/mL — impairs VO2max, mitochondrial function, and time-to-exhaustion measurably. Day 1–2 workouts often feel genuinely harder, not just psychologically.

Peak training window. Estrogen is muscle-protective, reduces exercise-induced damage, and accelerates recovery. PRs and heavy training blocks belong in the follicular and ovulatory phases. Response to strength training is measurably better in this window due to estrogen's synergy with anabolic signaling.

Maximum power output. Peak coordination and reaction time. Also the highest injury risk window — estrogen at its peak loosens ligaments and increases ACL injury risk in female athletes. Power but also caution.

The progesterone and heat phase. Core temperature is elevated 0.3–0.5°C — affecting endurance performance in heat more than a male athlete would experience. Insulin sensitivity is lower — pre-workout carbohydrate fueling becomes more important. Recovery is slower. This is the adaptation phase, not the test-yourself phase.

If cycling has resumed, the first several postpartum cycles are often irregular, heavier than pre-pregnancy, and more symptomatic. The uterus is still remodeling. Iron depletion from birth may not have fully recovered.

Depends heavily on sleep deprivation, breastfeeding status, and time since birth. For breastfeeding parents, prolactin remains elevated and suppresses estrogen — the "follicular phase" may be hormonally blunted for months. When sleep deprivation is the dominant variable, all phase benefits are muted.

Ovulation may return before the first period (the first postpartum period is preceded by ovulation). Libido is often significantly suppressed by prolactin, low estrogen from breastfeeding, and the cortisol of new-parent stress — not a psychological failure, a hormonal one.

Postpartum mood disorders (PPD, PPA, postpartum psychosis) are not a function of the cycle — they are caused by the precipitous fall in estrogen and progesterone at birth, the steepest hormonal drop in human physiology. Ongoing luteal-phase mood fluctuations in the postpartum year may be amplified by still-recovering HPG axis regulation.

Often the most unpredictable and painful phase in the teen years. Prostaglandin levels are high and the body hasn't yet learned to moderate them efficiently. Heavy bleeding is common and frequently dismissed as normal — but iron loss is real and compounds fatigue and cognitive performance at school.

The HPG axis is still calibrating, so the follicular phase may be short, long, or inconsistent cycle to cycle. The estrogen rise that brings energy and mood lift is genuine but inconsistent. Some teen cycles are anovulatory early on — follicles develop but don't always complete the process.

May not occur in every cycle for the first 1–2 years. When ovulation does happen, the hormonal surge is felt — but irregular timing means it's harder to anticipate. LH test strips can help identify ovulation even in irregular cycles.

Without consistent ovulation, the luteal phase may be shortened or absent. When progesterone does rise, teens often experience it more intensely — mood swings and PMS symptoms tend to be sharpest in adolescence as the nervous system acclimates to the hormonal rhythm for the first time.

Periods are often light or short — sometimes barely a bleed. Low estrogen means the uterine lining didn't build substantially. While lighter flow sounds appealing, it can signal that estrogen didn't reach levels needed to support other systems: bone density, vaginal health, cardiovascular function.

The phase where low estrogen is most felt. The usual follicular rise that lifts energy, mood, and libido is blunted or absent. Brain fog, joint stiffness, and low motivation that are typically relief-phase symptoms persist into what should be the recovery window.

The LH surge may still occur but the estrogen peak preceding it is muted. Libido at ovulation — normally near its highest — may remain flat. Cervical fluid is often reduced. If estrogen is very low, ovulation may not occur at all.

Without adequate estrogen to support the second half of the cycle, the luteal progesterone rise feels amplified in comparison — even normal progesterone levels can feel sedating when estrogen isn't present to counterbalance. Sleep disruption, low energy, and flat mood are common throughout.

Thyroid dysfunction slows everything, including uterine contractions and clot clearance. Periods with hypothyroidism are often heavy, prolonged, and accompanied by stronger cramping. Iron depletion accelerates because flow is heavier than baseline. Fatigue during menstruation becomes extreme.

The follicular energy lift that depends on estrogen and metabolic activity is significantly blunted by hypothyroidism. Insulin sensitivity and mitochondrial efficiency — both of which thyroid hormones support — are impaired. The week that should feel like recovery often doesn't.

Thyroid dysfunction interferes with LH surge timing and can cause anovulatory cycles. When ovulation does occur, it may be later than expected. The brain fog that accompanies hypothyroidism doesn't lift at ovulation the way it does in typical cycles.

The progesterone-driven fatigue of the luteal phase stacks directly on top of the thyroid-driven fatigue. This is when hypothyroid symptoms are often at their most severe. Sleep is poor despite exhaustion — a thyroid signature. Hair loss, which peaks in the luteal phase hormonally, is amplified in thyroid conditions.

The most symptomatic phase. Endometrial tissue outside the uterus responds to the same hormonal signals as uterine lining — swelling, bleeding, and causing inflammation wherever it's implanted. Pain is often debilitating, may radiate to the back, legs, and bowel, and can persist for the entire duration of the period. Many with endo describe menstruation as the worst week of their month.

The most functional phase for most people with endometriosis. Rising estrogen unfortunately also feeds endo tissue growth — the follicular phase is when endo lesions are most actively proliferating — but pain is typically at its lowest since there's no bleeding-triggered inflammation.

Mittelschmerz (ovulation pain) is often significantly worse in endometriosis, particularly if endo lesions are near the ovaries. The estrogen peak at ovulation can trigger a flare in some. Painful sex, if present, is typically worst around ovulation due to pelvic congestion.

Progesterone has a partial anti-inflammatory effect — many with endometriosis feel somewhat better in the early and mid-luteal phase. As progesterone falls at the end of the luteal phase and inflammation rises, symptoms begin to creep back before the period even starts. The pre-period pain that begins 3–5 days early is a hallmark of endometriosis.

The defining phase of the fibroid pattern. Submucosal and intramural fibroids distort the uterine cavity and prevent it from contracting efficiently — the result is significantly heavier, longer bleeding with large clots. Iron-deficiency anemia is more common in this population than almost any other menstrual pattern. The first 2 days can require changing protection every hour or less.

Rising estrogen actively stimulates fibroid growth — fibroids have more estrogen receptors than surrounding myometrium. Each follicular phase is an opportunity for fibroids to grow slightly. The pelvic pressure and bloating that fibroids cause doesn't fully resolve between periods.

Estrogen at its peak means fibroid tissue is maximally stimulated. Pelvic pressure and heaviness are often noted around ovulation. Painful sex is common if fibroids are near the cervix or distort the uterine shape.

Progesterone also stimulates some fibroid growth, particularly in the early luteal phase. As the period approaches, pelvic congestion and heaviness increase in anticipation of the heavy bleed ahead. The psychological weight of knowing what's coming — days of heavy bleeding — is a real quality-of-life factor that is often underdiscussed.

When a period does return after HA, it often signals that the body has reached a caloric and physiological threshold of safety. The first returning period after amenorrhea may be heavier than expected as the lining sheds after an extended build-up. It is a sign of recovery, not relapse.

With HA, the hypothalamus suppresses GnRH, which means FSH and LH are low — follicular development is arrested. The "follicular phase" doesn't really occur in the hormonal sense. Estrogen remains low. Bone density is at greatest risk during extended HA, as estrogen's protective effect on bone is absent.

Ovulation is absent by definition in hypothalamic amenorrhea. The LH surge doesn't occur. This is the central feature of HA — reproductive function is suspended because the hypothalamus has interpreted insufficient caloric intake or excessive stress as incompatible with pregnancy.

Without ovulation, there is no corpus luteum and no luteal progesterone. The hormonal landscape is uniformly flat — low estrogen and low progesterone. Mood, sleep, and energy are often surprisingly stable because there are no hormonal swings, but the absence of these hormones carries significant costs to bone, cardiovascular, and brain health over time.

No menstruation. The cycle architecture is gone. What remains is a new hormonal steady state — low estrogen, low progesterone, and elevated FSH and LH as the pituitary continues trying to stimulate ovaries that no longer respond.

The concept of a follicular phase no longer applies. FSH is permanently elevated — not because follicles are developing, but because the feedback loop that would suppress it (a rising follicle secreting estrogen) is gone. This elevated FSH is what causes hot flashes, as FSH acts on hypothalamic receptors involved in thermoregulation.

No LH surge, no ovulation. The midcycle hormonal peak that once drove energy, libido, and social drive is absent. Some post-menopausal people describe a flattening of emotional peaks and valleys — the dramatic month-to-month variability of reproductive years is replaced by a steadier, lower-amplitude hormonal baseline.

No progesterone production from a corpus luteum. Sleep architecture shifts — the deep sleep that progesterone supports is reduced. Hot flashes are often worst at night, disrupting sleep independently. The window that was once the most symptomatic part of the cycle no longer exists in that form, though the underlying mechanisms (low serotonin, low GABA-A support) persist in a new steady state.

The first post-pill period often arrives 4–8 weeks after stopping, sometimes longer. It may be heavier than pill-bleed withdrawal periods because the endometrium is building a real hormonally-driven lining again. Some people don't recognize their own cycle at first — the contrast with the predictable pill pack schedule is disorienting.

The HPG axis restarts, but depleted nutrient cofactors from years of pill use can blunt the follicular phase recovery. B6, B12, folate, zinc, and magnesium are all involved in estrogen synthesis and metabolism — and all are measurably depleted by combined OCP use. The "post-pill low" many people describe in the first 3–6 months is partly this depletion.

Ovulation typically returns within 1–3 months but the timing is irregular as the HPG axis recalibrates. LH surge testing helps identify when ovulation resumes. The first few ovulatory cycles may have a blunted estrogen peak as the axis finds its rhythm.

The first few luteal phases post-pill can be rocky. Progesterone production restarts but may be insufficient initially, leading to shortened luteal phases and pre-period spotting. The mood and symptom patterns that the pill was suppressing may return — sometimes more intensely at first as the body overshoots before finding its new equilibrium.

Regular, predictable, manageable. Cramping is present but controlled. Iron loss is real but not acute. The key distinction of this pattern is that symptoms — while genuine — are proportionate and don't derail function. This phase is best used for deliberate rest and recovery rather than pushing through.

The full follicular benefit is available. Energy lifts, mood brightens, cognitive performance improves measurably week over week. This is the phase where new habits, ambitious projects, and social investment tend to feel most natural and sustainable.

Peak performance across most domains. The social drive, libido, and confidence are at their strongest. For the in-flow pattern, this is the phase to leverage for high-stakes work, conversations, and physical output — it is a real and reliable window, not just wellness narrative.

The phase that most benefits from proactive support. Even in a healthy cycle, the luteal progesterone-serotonin-sleep interaction asks something of the nervous system. This pattern experiences it as manageable fatigue and mild inwardness rather than dysfunction — but intentional nutrition, reduced alcohol, and maintained sleep hygiene noticeably improve how this phase lands.

For people on gender-affirming HRT or complex hormone regimens, menstruation is either absent or fundamentally altered. The endogenous cycle architecture doesn't apply. Symptom patterns are determined by the specific HRT protocol — estradiol form, dose, and progestogen type each create distinct experiences.

Exogenous estrogen creates a more stable hormonal environment than endogenous cycling — without the LH-surge-driven ovulatory spike or the sudden progesterone crash. Many people on stable HRT describe a more even emotional baseline compared to cycling years, though they may also miss the peaks.

No endogenous LH surge on suppressive HRT. The midcycle energy and libido peak that the cycle architecture creates is replaced by whatever the HRT protocol provides. Testosterone levels — which drive libido in all hormone profiles — are a key variable worth discussing with a prescriber if libido is a concern.

If a progestogen is included in the HRT regimen, progestogen sensitivity (similar to natural progesterone sensitivity) is real. Some people on medroxyprogesterone acetate or other synthetic progestins experience mood effects comparable to natural luteal symptoms. Micronized progesterone (bioidentical) tends to produce fewer mood side effects due to its conversion to allopregnanolone.